{
    "SPADE_UN_25683": {
        "Sequence Information": {
            "Peptide Name": "Daptomycin 3a",
            "Sequence": "WNDTGXDADGSXX",
            "Sequence Length": 13,
            "Biological Activity": [
                "Anti-Gram+"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Structure-Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea.",
                    "Pubmed ID": "25993059",
                    "Reference": "J Med Chem. 2015;58:5137-5142",
                    "Author": "Yin N, Li J, He Y, Herradura P, Pearson A, Mesleh MF, Mascio CT, Howland K, Steenbergen J, Thorne GM, Citron DM, Van Praagh AD, Mortin LI, Keith D, Silverman J, Metcalf C",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25993059"
                }
            ],
            "SPADE ID": "SPADE_UN_25683",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_05600",
                    "Similarity": 1.0,
                    "Sequence": "WNDTGKDADGSEY"
                },
                {
                    "SPADE_ID": "SPADE_UN_25580",
                    "Similarity": 1.0,
                    "Sequence": "WNDTGDADGSEW"
                },
                {
                    "SPADE_ID": "SPADE_UN_25582",
                    "Similarity": 1.0,
                    "Sequence": "WNDTGDADGSEY"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "Clostridioides difficile(MIC90=4µg/ml),Staphylococcus aureus ATCC 29213(MIC=2µg/ml),Enterococcus faecium ATCC 6569(MIC=>32µg/ml),Enterococcus faecalis ATCC 49452(MIC=32µg/ml)"
        }
    }
}